Aurora Investment Counsel Neurocrine Biosciences Inc Transaction History
Aurora Investment Counsel
- $166 Million
- Q1 2025
A detailed history of Aurora Investment Counsel transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Aurora Investment Counsel holds 10,520 shares of NBIX stock, worth $1.32 Million. This represents 0.7% of its overall portfolio holdings.
Number of Shares
10,520
Previous 10,382
1.33%
Holding current value
$1.32 Million
Previous $1.42 Million
17.93%
% of portfolio
0.7%
Previous 0.85%
Shares
10 transactions
Others Institutions Holding NBIX
# of Institutions
649Shares Held
97.6MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.78 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.25 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$694 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$610 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$335 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...